Vimarsana
Biggest News Aggregation in the World

Page 11 - Bishop Rhoades News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bishop Rhoades. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bishop Rhoades Today - Breaking & Trending Today

Pharmaceutical companies urged to stop using abortion-derived cell lines - Vimarsana News

Pharmaceutical companies urged to stop using abortion-derived cell lines

04/25/2021 at 9:40 PM Posted by Kevin Edward White By Catholic News Service, April 14, 2021 WASHINGTON (CNS) — The U.S. Conference of Catholic Bishops’ Secretariat of Pro-Life Activities has launched a campaign urging Catholics to write letters to pharmaceutical companies urging them to stop the use of abortion-derived cell lines in the development and testing of vaccines. Among the companies singled out are Pfizer, Moderna, AstraZeneca and Johnson & Johnson for their COVID-19 vaccines, GlaxoSmithKline for its Shingrix shingle vaccine, and Merck for its MMR, Chickenpox, and Hepatiti...

Companies urged to stop using abortion-derived cell lines - Arkansas Catholic - Vimarsana News

Companies urged to stop using abortion-derived cell lines - Arkansas Catholic

A nurse prepares a dose of AstraZeneca COVID-19 vaccine in Fasano, Italy, April 13, 2021. CNS photo/Alessandro Garofalo, Reuters A nurse prepares a dose of AstraZeneca COVID-19 vaccine in Fasano, Italy, April 13, 2021. WASHINGTON (CNS) -- The U.S. Conference of Catholic Bishops' Secretariat of Pro-Life Activities has launched a campaign urging Catholics to write letters to pharmaceutical companies urging them to stop the use of abortion-derived cell lines in the development and testing of vaccines. Among the companies singled out are Pfizer, Moderna, AstraZeneca and Johnson & Johnson for thei...

Big pharmas urged to stop using abortion-derived cell lines - Vimarsana News

Big pharmas urged to stop using abortion-derived cell lines

Big pharmas urged to stop using abortion-derived cell lines Vials of the Johnson & Johnson COVID-19 vaccine and a medical syringe are seen in this 2020 photo illustration. (CNS photo/Dado Ruvic, Reuters) By Julie Asher • Catholic News Service • Posted April 14, 2021 WASHINGTON (CNS) — The U.S. Conference of Catholic Bishops’ Secretariat of Pro-Life Activities has launched a campaign urging Catholics to write letters to pharmaceutical companies urging them to stop the use of abortion-derived cell lines in the development and testing of vaccines. Among the companies singled out are P...

Pharmaceutical Companies Urged to Stop Using Abortion-Derived Cell Lines - Vimarsana News

Pharmaceutical Companies Urged to Stop Using Abortion-Derived Cell Lines

Pharmaceutical Companies Urged to Stop Using Abortion-Derived Cell Lines April 14, 2021 A nurse prepares a dose of AstraZeneca COVID-19 vaccine in Fasano, Italy, April 13, 2021. (Photo: CNS/Alessandro Garofalo, Reuters) By Julie Asher WASHINGTON (CNS) — The U.S. Conference of Catholic Bishops’ Secretariat of Pro-Life Activities has launched a campaign urging Catholics to write letters to pharmaceutical companies urging them to stop the use of abortion-derived cell lines in the development and testing of vaccines. Among the companies singled out are Pfizer, Moderna, AstraZeneca and ...

Catholic scholars: Any available COVID-19 vaccine is morally acceptable - Vimarsana News

Catholic scholars: Any available COVID-19 vaccine is morally acceptable

Catholic scholars: Any available COVID-19 vaccine is morally acceptable Friday, Mar. 19, 2021 By Catholic News Service WASHINGTON — A group of prominent Catholic scholars said they believe it is morally acceptable for anyone to receive any of the COVID-19 vaccines currently available in the United States. “Catholics, and indeed, all persons of goodwill who embrace a culture of life for the whole human family, born and unborn, can use these vaccines without fear of moral culpability” for abortion, the eight scholars said in a statement released March 5 through the Ethics and Public Polic...